A new monoclonal antibody targets a particular region of the receptor-binding domain (RBD) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This region is usually not accessible to immune cells, which may be why it has broad neutralizing capabilities….
Read More
IDSA Updates COVID-19 Treatment Guidelines: Monoclonals and More
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. While there is still no “game-changer” for treating COVID-19, the Infectious Diseases Society of America (IDSA) continues to examine available and potential treatments as new evidence…
Read More